Showing results (321-330 of 486) with videos related to
Sort By:
Pageof 49
Journal of Magnetic Resonance Imaging : JMRI|March 24, 2020
Response to Letter: Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of HCA From FNHMaarten G Thomeer, Inge J S M L Vanhooymissen, Loes M M Braun, et al.Patient Education and Counseling|August 13, 2016
Psychosocial predictors of DMARD adherence in the first three months of treatment for early arthritisAnnelieke Pasma, Johanna M W Hazes, Jan J V Busschbach, et al.Journal of Virology|February 19, 2016
Hepatitis E Virus (HEV) Genotype 3 Infection of Human Liver Chimeric Mice as a Model for Chronic HEV InfectionMartijn D B van de Garde, Suzan D Pas, Guido van der Net, et al.Pediatric Radiology|March 31, 2016
Automated radiogrammetry is a feasible method for measuring bone quality and bone maturation in severely disabled childrenSandra Mergler, Stella A de Man, Annemieke M Boot, et al.European Journal of Gastroenterology & Hepatology|May 20, 2016
Hepatocellular carcinoma in noncirrhotic livers is associated with steatosis rather than steatohepatitis: potential implications for pathogenesisSuzanne van Meer, Karel J van Erpecum, Dave Sprengers, et al.The Journal of Infectious Diseases|January 8, 2008
A prospective open study of the efficacy of high-dose recombinant hepatitis B rechallenge vaccination in HIV-infected patientsTheodora E M S de Vries-Sluijs, Bettina E Hansen, Gerard J J van Doornum, et al.Gut|June 22, 2002
Prospective comparative study of spiral computer tomography and magnetic resonance imaging for detection of hepatocellular carcinomaJ Stoker, M G Romijn, R A de Man, et al.Journal of Magnetic Resonance Imaging : JMRI|April 26, 2012
Histological differentiation grade and microvascular invasion of hepatocellular carcinoma predicted by dynamic contrast-enhanced MRICaroline D M Witjes, François E J A Willemssen, Joanne Verheij, et al.The Journal of Infectious Diseases|October 3, 2020
Differential gene expression, irrespective of circulating Hepatitis B Surface Antigen levels, between Inactive Carrier and Nucleos(t)ide Analogue-Treated Hepatitis B Virus patientsNoé R Montanari, Nádia Conceição-Neto, Ilse Van Den Wyngaert, et al.The Journal of Infectious Diseases|December 9, 2017
HBV-Derived Synthetic Long Peptide Can Boost CD4+ and CD8+ T-Cell Responses in Chronic HBV Patients Ex VivoYingying Dou, Nadine van Montfoort, Aniek van den Bosch, et al.Pageof 49